Topical bioavailability of triamcinolone acetonide: effect of occlusion. 2007

C Pellanda, and C Strub, and V Figueiredo, and T Rufli, and G Imanidis, and C Surber
Hospital Pharmacy, University Hospital Basel, Basel, Switzerland.

OBJECTIVE Occlusion by covering the skin with an impermeable wrap enhances skin hydration, affects drug absorption and can induce the formation of a drug reservoir within the stratum corneum. This is desired in local therapy with topical corticosteroids. The aim of the study was to investigate the effect of occlusion before (experiment 1) and after (experiment 2) application on the penetration of triamcinolone acetonide (TACA) into the stratum corneum. METHODS The experiments were conducted on the forearms of 10 healthy volunteers. In experiment 1, 100 microg/cm(2) TACA in acetone were applied on 3 sites per arm, one arm having been pre-occluded for 16 h. In experiment 2, the same dose was applied on 2 sites per arm, and one arm was occluded after application until skin sampling. Stratum corneum samples were removed by tape stripping at 0.5, 4 and 24 h (experiment 1) and 4 and 24 h (experiment 2) after application. Corneocytes and TACA were quantified by ultraviolet-visible spectroscopy and HPLC, respectively. The total TACA amount penetrated into the stratum corneum was evaluated by multifactor ANOVA. RESULTS TACA penetration into the stratum corneum with and without pre-occlusion (experiment 1) showed no significant difference and decreased with time. Occlusion after application (experiment 2) produced a marked TACA accumulation within the stratum corneum, which persisted for 24 h. CONCLUSIONS Pre-occlusion showed no effect on the topical bioavailability of TACA in the stratum corneum. In contrast, post-occlusion enhanced the TACA penetration by a factor of 2, favouring the development of a drug reservoir.

UI MeSH Term Description Entries
D008297 Male Males
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001458 Bandages Material used for wrapping or binding any part of the body. Dressings,Bandage,Dressing
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D012869 Skin Absorption Uptake of substances through the SKIN. Absorption, Skin,Intracutaneous Absorption,Intradermal Absorption,Percutaneous Absorption,Transcutaneous Absorption,Transdermal Absorption,Absorption, Intracutaneous,Absorption, Intradermal,Absorption, Percutaneous,Absorption, Transcutaneous,Absorption, Transdermal,Absorptions, Intracutaneous,Absorptions, Intradermal,Absorptions, Percutaneous,Absorptions, Skin,Absorptions, Transcutaneous,Absorptions, Transdermal,Intracutaneous Absorptions,Intradermal Absorptions,Percutaneous Absorptions,Skin Absorptions,Transcutaneous Absorptions,Transdermal Absorptions
D014222 Triamcinolone Acetonide An esterified form of TRIAMCINOLONE. It is an anti-inflammatory glucocorticoid used topically in the treatment of various skin disorders. Intralesional, intramuscular, and intra-articular injections are also administered under certain conditions. Azmacort,Cinonide,Kenacort A,Kenalog,Kenalog 40,Tricort-40,Acetonide, Triamcinolone,Tricort 40,Tricort40

Related Publications

C Pellanda, and C Strub, and V Figueiredo, and T Rufli, and G Imanidis, and C Surber
August 1965, Archives of dermatology,
C Pellanda, and C Strub, and V Figueiredo, and T Rufli, and G Imanidis, and C Surber
August 1965, Archives of dermatology,
C Pellanda, and C Strub, and V Figueiredo, and T Rufli, and G Imanidis, and C Surber
March 1962, El Dia medico,
C Pellanda, and C Strub, and V Figueiredo, and T Rufli, and G Imanidis, and C Surber
October 2017, AAPS PharmSciTech,
C Pellanda, and C Strub, and V Figueiredo, and T Rufli, and G Imanidis, and C Surber
January 1960, Antibiotic medicine & clinical therapy (New York, NY),
C Pellanda, and C Strub, and V Figueiredo, and T Rufli, and G Imanidis, and C Surber
January 1968, Acta dermato-venereologica,
C Pellanda, and C Strub, and V Figueiredo, and T Rufli, and G Imanidis, and C Surber
November 1958, A.M.A. archives of dermatology,
C Pellanda, and C Strub, and V Figueiredo, and T Rufli, and G Imanidis, and C Surber
August 1963, Current therapeutic research, clinical and experimental,
C Pellanda, and C Strub, and V Figueiredo, and T Rufli, and G Imanidis, and C Surber
August 1963, Current therapeutic research, clinical and experimental,
C Pellanda, and C Strub, and V Figueiredo, and T Rufli, and G Imanidis, and C Surber
August 1970, British dental journal,
Copied contents to your clipboard!